← Open Payments lookup

AMY RIVAS: Open Payments

NPI 1699244830 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$7,716 in 222 payments from 29 companies in 2025. Trend: 2023 $1,023 · 2024 $4,691 · 2025 $7,716

Food & beverage: $6,530Travel & lodging: $1,186
CompanyPaymentsAmount
Medtronic, Inc.35$2,413
Sequel Med Tech, LLC26$746
Novo Nordisk Inc21$683
Amgen Inc.16$475
Lilly USA, LLC20$458
Corcept Therapeutics15$450
Insulet Corporation7$377
Madrigal Pharmaceuticals7$349
Boehringer Ingelheim Pharmaceuticals, Inc.14$267
Tandem Diabetes Care, Inc.5$198

Products named: MINIMED 780G, TWIIST, INPEN SMART INSULIN DELIVERY SYSTEM, Korlym, JARDIANCE, Omnipod, REZDIFFRA, Ozempic.

Industry payments across TX — which companies pay providers there.